Abstract: An API adapter generation device include a conversion rule calculation unit (16) configured to acquire a data model of an orchestrator (210) and an API specification to be managed and perform schema matching on the basis of a data schema of the orchestrator and a data schema of the API specification to calculate a model conversion rule, a call logic unit generation unit (19) configured to rewrite a source code of an API call logic unit 232 describing an API adapter execution logic on the basis of the model conversion rule, and an API adapter generation unit (21) configured to generate an API adapter to be managed on the basis of the API call logic unit in which the source code is rewritten.

Abstract: [Problem] To provide a compound having a 15-PGDH inhibitory effect. [Solution] A compound represented by general formula (1) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: A capacitor that includes a conductive metal substrate having a high porosity portion and a low porosity portion with a porosity lower than that of the high porosity portion; a dielectric layer on the conductive metal substrate; an upper electrode on the dielectric layer; an upper extended electrode on one principal face of the conductive metal substrate and electrically connected to the upper electrode; a lower extended electrode on the other principal face of the conductive metal substrate and electrically connected to the conductive metal substrate; and insulating layer on the upper electrode at a position overlapping with the low porosity portion through the dielectric layer and the upper electrode.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: To provide a highly active herbicidal composition to control undesired plants by synergistic herbicidal effects. The present invention provides a herbicidal composition comprising (A) metobromuron or its salt, and (B) at least one herbicidal compound selected from the group consisting of chlorpropham, S-metolachlor, flufenacet, pyroxasulfone, nicosulfuron, fluazifop-P-butyl, prometryn, ioxynil, pendimethalin, trifluralin, prosulfocarb, thiobencarb and indanofan, or its alkyl ester or its salt; and a herbicidal method of using it.

Abstract: A method capable of manufacturing a quartz vibrator by disposing a metallic bonding material on one main surface of a ceramic plate having a quartz vibrating element mounted thereon. Thereafter, the bonding of a cap having a recess to the ceramic plate by disposing the cap on the one main surface of the ceramic plate so that an open side of the recess faces the ceramic plate, melting the bonding material, and then allowing the bonding material to set, is carried out.

Abstract: A capacitor that includes a conductive metal substrate having a high porosity portion and a low porosity portion with a porosity lower than that of the high porosity portion; a dielectric layer on the conductive metal substrate; an upper electrode on the dielectric layer; an upper extended electrode on one principal face of the conductive metal substrate and electrically connected to the upper electrode; a lower extended electrode on the other principal face of the conductive metal substrate and electrically connected to the conductive metal substrate; and insulating layer on the upper electrode at a position overlapping with the low porosity portion through the dielectric layer and the upper electrode.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: A crystal resonation device that includes a base plate, a cap, a joining material, and a crystal resonator. The cap is provided on the base plate. The cap forms a sealed space with the base plate. The joining material joins the base plate and the cap. The joining material contains a cured material of thermosetting resin. The crystal resonator is provided on the base plate in the sealed space. The joining material is located in an outer side portion of a wall of the cap joined to the joining material.

Abstract: To provide a highly active herbicidal composition to control undesired plants by synergistic herbicidal effects. The present invention provides a herbicidal composition comprising (A) metobromuron or its salt, and (B) at least one herbicidal compound selected from the group consisting of chlorpropham, S-metolachlor, flufenacet, pyroxasulfone, nicosulfuron, fluazifop-P-butyl, prometryn, ioxynil, pendimethalin, trifluralin, prosulfocarb, thiobencarb and indanofan, or its alkyl ester or its salt; and a herbicidal method of using it.

Abstract: Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect. The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.

Abstract: A quartz vibrator that includes a substrate, a quartz vibrating element, and a dome-shaped cap. The quartz vibrating element is mounted on the substrate. The cap is bonded to the substrate. The cap defines and forms a sealed space that seals the quartz vibrating element along with the substrate. The cap has a side wall portion, a ceiling portion, and a connecting portion. The side wall portion encloses the quartz vibrating element. The ceiling portion is positioned above the quartz vibrating element. The connecting portion connects the side wall portion and the ceiling portion. The connecting portion is thinner than the side wall portion and the ceiling portion.